# MarketFlow Predictive-Usefulness Acceptance Readiness Review Using Expectancy Lab Evidence v1 Plan

## Purpose

Create a deterministic, offline readiness review from the completed expectancy-lab reassessment. The review decides whether current evidence is ready for an acceptance candidate without accepting predictive usefulness or creating downstream authority.

## Source Reassessment and Bound Evidence

Bind `MARKETFLOW_PREDICTIVE_USEFULNESS_REASSESSMENT_USING_EXPECTANCY_LAB_EVIDENCE_PACKAGE`, digest `7befe5693744d4b44aa8243270d43bfb7727ae324bc911a2cf5c68bc9ad86bd7`, plus the complete results-review, execution, output-binding, row, metric, approval, VPA/Wyckoff, matrix, target, records, and upstream evidence chain. Use committed constants or an already-built validated reassessment; never rerun the reassessment.

## Dataset and Universe

Preserve the frozen `expanded_universe_canonical_dataset_v1`, 1d RTH profile, 2022–2025 range, exact ordered 12-ticker universe, 11,946 records, and records digest. Preserve META at 913 and all other tickers at 1,003.

## Readiness Basis

Bind 179,190 lab rows, 177,090 evaluable outcomes, 2,100 unavailable outcomes, 4,200 embargoed rows, and 172,890 aggregate-eligible rows. Preserve 13 approved and one blocked metric family, six approved and one blocked baseline, and zero output digest mismatches.

## Readiness Criteria and Findings

Evaluate sixteen research-only criteria. Integrity, no-peek, report presence, alignment, abstention, and closed boundaries pass. Chronology passes with reviewed embargo exclusions. META passes with operator awareness. Per-ticker stability requires operator review. Metric materiality, baseline-outperformance materiality, an approved acceptance threshold, and the source recommendation do not support readiness.

## Metric Materiality and Baseline Outperformance

Current reviewed metrics and baseline comparisons do not establish acceptance materiality. They remain research-only evidence and do not justify an acceptance candidate.

## Per-Ticker Stability

Preserve one deterministic readiness entry per ticker. Current per-ticker stability remains `REQUIRES_OPERATOR_REVIEW`; it is not inferred to be acceptance evidence.

## Chronology, Embargo, and No-Peek

Preserve chronological no-shuffle splits, reviewed embargo exclusions, and passing no-peek/leakage controls. Do not inspect raw rows or recompute any metric.

## META Limitation

META remains 913 historical records, 13,695 lab rows, 13,520 evaluable outcomes, and 175 unavailable outcomes. Preserve the limitation without repair, smoothing, normalization, inference, or fabrication.

## Decision

Set `MARKETFLOW_PREDICTIVE_USEFULNESS_ACCEPTANCE_NOT_READY_USING_EXPECTANCY_LAB_EVIDENCE`. Keep acceptance-candidate readiness false and readiness for the not-ready closure/method-selection path true. Recommend `DO_NOT_CREATE_PREDICTIVE_USEFULNESS_ACCEPTANCE_CANDIDATE`.

## Next Chain and Gates

Proceed only to the not-ready closure/method planning tree. A later operator may choose closure/archive or separately select an improvement path. New evidence requires separate approval; reassessment and readiness reruns require new evidence. Acceptance, profitability, and runtime remain later separate gates.

## Risk Controls, Non-Goals, and Guardrails

Do not call providers, acquire data, regenerate the dataset, inspect raw rows, recompute metrics, rerun sources, mutate ignored evidence, train models, score strategies, create recommendations or an acceptance candidate, accept predictive usefulness or profitability, or authorize runtime or trading. Keep `.marketflow` outputs ignored and untracked.

## Next Task

Predictive-Usefulness Not-Ready Closure and Method Planning Tree Using Expectancy Lab Evidence v1.
